CAS: 93772-31-7 - neogambogic acid
Formule :C38H46O9
InChI :InChI=1/C38H46O9/c1-19(2)10-9-14-36(8)18-25(39)27-30(41)28-29(40)24-16-22-17-26-35(6,7)47-37(33(22)42,15-13-21(5)34(43)44)38(24,26)46-32(28)23(31(27)45-36)12-11-20(3)4/h10-11,13,16,22,25-26,39,41H,9,12,14-15,17-18H2,1-8H3,(H,43,44)/b21-13+
- Synonymes :
- (2Z)-4-[(1S,8R,17S,19R)-10,12-Dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,11,15-tetraen-19-yl]-2-methylbut-2-enoic acid
- 2-butenoic acid, 4-[(1R,3aS,5S,11R)-3a,4,5,7,10,11-hexahydro-8,9-dihydroxy-3,3,11-trimethyl-13-(3-methyl-2-buten-1-yl)-11-(4-methyl-3-penten-1-yl)-7,15-dioxo-1,5-methano-1H,3H,9H-furo[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methyl-, (2Z)-
- (2E)-4-[8,9-dihydroxy-3,3,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-7,15-dioxo-3a,4,5,7,10,11-hexahydro-3H,9H-1,5-methanofuro[3,4-g]pyrano[3,2-b]xanthen-1-yl]-2-methylbut-2-enoic acid
Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
---|---|---|---|---|
Neogambogic acid REF : 7W-GY2292CAS : 93772-31-7 | - - - | À demander | mar 10 Déc 24 | |
Neogambogic acid REF : BP-BP0990CAS : 93772-31-7 | 95%~99% | À demander | mer 11 Déc 24 | |
Neogambogic acid REF : TM-T5724CAS : 93772-31-7 | 97.74% - 99.38% | 50,00 €~509,00 € | mar 17 Déc 24 | |
Neogambogic Acid REF : TR-N389875CAS : 93772-31-7 | - - - | 1.573,00 € | mar 21 Jan 25 | |
Neogambogic acid REF : 3D-FN11496CAS : 93772-31-7 | Min. 95% | 2.319,00 €~5.217,00 € | mar 04 Fév 25 |
Ref: 7W-GY2292
Taille indéfinie | À demander |
Neogambogic acid
Ref: BP-BP0990
Taille indéfinie | À demander |
Neogambogic acid
Ref: TM-T5724
1mg | 50,00 € | ||
5mg | 95,00 € | ||
10mg | 143,00 € | ||
25mg | 233,00 € | ||
50mg | 343,00 € | ||
100mg | 509,00 € |
Neogambogic Acid
Produit contrôléRef: TR-N389875
25mg | 1.573,00 € |
Neogambogic acid
Ref: 3D-FN11496
1g | 5.217,00 € | ||
100mg | 2.319,00 € | ||
250mg | 2.898,00 € | ||
500mg | 4.058,00 € |